End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.7 CNY | +2.49% | +10.45% | -12.32% |
25/04 | Huaren Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2023 | CI |
24/04 | Huaren Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2022 | 1.62B 224M 18.67B | Sales 2023 | 1.64B 226M 18.86B | Capitalization | 4.99B 689M 57.5B |
---|---|---|---|---|---|
Net income 2022 | 181M 25M 2.09B | Net income 2023 | 188M 25.97M 2.17B | EV / Sales 2022 | 3.99 x |
Net Debt 2022 | 1.45B 200M 16.71B | Net Debt 2023 | 1.65B 228M 19.01B | EV / Sales 2023 | 4.06 x |
P/E ratio 2022 |
27.7
x | P/E ratio 2023 |
26.5
x | Employees | 2,264 |
Yield 2022 |
0.5% | Yield 2023 |
-
| Free-Float | 36.65% |
1 day | +2.49% | ||
1 week | +10.45% | ||
Current month | +3.35% | ||
1 month | +3.35% | ||
3 months | -1.86% | ||
6 months | -14.35% | ||
Current year | -12.32% |
Managers | Title | Age | Since |
---|---|---|---|
Liang Hong
CEO | Chief Executive Officer | 53 | 29/22/29 |
Li Ping Han
DFI | Director of Finance/CFO | 39 | 26/20/26 |
Xiao Dong Yang
CHM | Chairman | 56 | 19/19/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gen Fu Feng
BRD | Director/Board Member | 67 | 28/19/28 |
Tian Xi Zhang
BRD | Director/Board Member | 67 | 28/19/28 |
Li Qiang
CHM | Chairman | 63 | 06/19/06 |
Date | Price | Change | Volume |
---|---|---|---|
30/24/30 | 3.7 | +2.49% | 21,223,840 |
29/24/29 | 3.61 | +2.85% | 13,866,180 |
26/24/26 | 3.51 | +1.45% | 16,337,730 |
25/24/25 | 3.46 | +1.76% | 19,695,060 |
24/24/24 | 3.4 | +0.89% | 11,145,420 |
End-of-day quote Shenzhen S.E., April 30, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-12.32% | 604M | |
+19.27% | 43.18B | |
+24.09% | 23.23B | |
+15.11% | 14.6B | |
+12.33% | 13.54B | |
+38.36% | 11.5B | |
-7.89% | 6.79B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+10.21% | 5.31B |
- Stock Market
- Equities
- 300110 Stock